483
CorneaGen - BostonCorneaGen - Boston – FDA 483, Dec 20, 2024
Record Details
CorneaGen - Boston, a human tissue establishment, was cited for significant deficiencies related to donor eligibility and product distribution during an FDA inspection. The firm failed to properly determine ineligible donors with clinical evidence of sepsis and distributed corneas before completing donor eligibility determinations. These issues indicate a serious lapse in ensuring the safety and suitability of human tissue products.
View Company Profile
ID · 8df31cfa-8379-47c9-8841-a09d6d074a37
Other documents for CorneaGen - Boston
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.